What is Timilon?
Founded in 2013, Timilon specializes in the development and manufacturing of patented technologies designed to capture and eliminate chemical and biological toxins. By providing comprehensive solutions for both surface and air contaminants, the company addresses urgent safety requirements in educational, military, and commercial environments. Their market position is defined by a commitment to environmentally safe, high-efficacy neutralization, allowing them to serve as a vital partner for organizations managing complex pathogen and nuisance contaminant risks. Through its robust R&D pipeline, Timilon continues to refine its application systems to meet evolving international safety standards.
How much funding has Timilon raised?
Timilon has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Timilon
PPP
Public-Private Partnership
What's next for Timilon?
With this latest infusion of capital, Timilon is poised to accelerate its market penetration and enhance its manufacturing throughput. The strategic focus will likely shift toward expanding its international footprint and deepening its integration within governmental and industrial supply chains. As the demand for advanced air and surface purification technologies remains elevated, the company is expected to leverage its existing intellectual property to capture additional market share. Future growth will be predicated on the successful deployment of these resources to optimize production efficiency and broaden the reach of its decontamination systems in high-stakes environments.
See full Timilon company page
